CFO of Array BioPharma Inc. (ARRY, Financial) Michael Carruthers sells 925 shares of ARRY on 07/30/2009 at an average price of $3.95 a share.
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company\'s proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. Array BioPharma Inc. has a market cap of $191 million; its shares were traded at around $3.97 with and P/S ratio of 6.6. Array BioPharma Inc. had an annual average earning growth of 32.7% over the past 5 years.
ARRY is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of Array BioPharma Inc. by CFO:
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company\'s proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. Array BioPharma Inc. has a market cap of $191 million; its shares were traded at around $3.97 with and P/S ratio of 6.6. Array BioPharma Inc. had an annual average earning growth of 32.7% over the past 5 years.
ARRY is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.
Recent Trades of Array BioPharma Inc. by CFO:
- Sell: CFO Michael Carruthers sold 1,170 shares of ARRY stock on 06/22/2009 at the average price of $3.06; the price of the stock has increased by 29.74% since.
- Sell: CFO Michael Carruthers sold 1,170 more shares of ARRY stock on 05/26/2009 at the average price of $3.13; the price of the stock has increased by 26.84% since.
